2020
DOI: 10.1038/s41374-019-0340-8
|View full text |Cite
|
Sign up to set email alerts
|

Arctigenin alleviates myocardial infarction injury through inhibition of the NFAT5-related inflammatory phenotype of cardiac macrophages/monocytes in mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
9
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 12 publications
(9 citation statements)
references
References 46 publications
0
9
0
Order By: Relevance
“…Arctigenin is a lignan derived from A. lappa , shown to have anti-inflammatory and cardioprotective effects ( 28 , 98 ). Yang et al ( 28 ) have evaluated the antiarrhythmic and antioxidant effects of ATG in a rat model of I/R injury.…”
Section: Resultsmentioning
confidence: 99%
“…Arctigenin is a lignan derived from A. lappa , shown to have anti-inflammatory and cardioprotective effects ( 28 , 98 ). Yang et al ( 28 ) have evaluated the antiarrhythmic and antioxidant effects of ATG in a rat model of I/R injury.…”
Section: Resultsmentioning
confidence: 99%
“…Mouse fibroblasts were isolated from 5-week-old C57BL/6 mice using enzymatic digestion according to our previous protocol 49 . Mouse heart pieces were enzymatically digested with stirring for 10 min, and the supernatant was collected.…”
Section: Cell Isolation and Culturementioning
confidence: 99%
“…For the beta-galactosidase activity of cardiac fibroblasts in vivo, 5-dodecanoylaminofluorescein di-β-D-galactopyranoside (C 12 FDG) was used according to a previous protocol 49 . Briefly, cardiac fibroblasts were isolated using enzymatic digestion and Percoll gradient separation.…”
Section: Beta-galactosidase Activity Assaymentioning
confidence: 99%
“…On the contrary, NFAT5 can also be detrimental following myocardial infarction. Arctigenin, a cardioprotective compound, was found to inhibit NFAT5 in cardiac macrophages [ 92 ]. More specifically, arctigenin binds the DNA-binding domain of NFAT5, thus inhibiting its ability to facilitate the NFκB signalling pathway and suppressing the conversion of macrophages to an inflammatory phenotype.…”
Section: Nfat5 Signalling In Cardiovascular Dysfunctionmentioning
confidence: 99%